Metropolitan Life Insurance Company (MetLife)’s ESCO Technologies ESE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,330
| Closed | -$142K | – | 694 |
|
|
2024
Q1 | $142K | Sell |
1,330
-144
| -10% | -$14.8K | 0.01% | 867 |
|
|
2023
Q4 | $173K | Hold |
1,474
| – | – | 0.01% | 804 |
|
|
2023
Q3 | $154K | Buy |
1,474
+81
| +6% | +$8.32K | 0.01% | 802 |
|
|
2023
Q2 | $144K | Hold |
1,393
| – | – | 0.01% | 826 |
|
|
2023
Q1 | $133K | Sell |
1,393
-168
| -11% | -$15.6K | 0.01% | 856 |
|
|
2022
Q4 | $137K | Hold |
1,561
| – | – | 0.01% | 896 |
|
|
2022
Q3 | $115K | Hold |
1,561
| – | – | 0.01% | 939 |
|
|
2022
Q2 | $107K | Hold |
1,561
| – | – | ﹤0.01% | 1020 |
|
|
2022
Q1 | $109K | Sell |
1,561
-4,991
| -76% | -$381K | ﹤0.01% | 1143 |
|
|
2021
Q4 | $590K | Sell |
6,552
-489
| -7% | -$42.3K | 0.01% | 1314 |
|
|
2021
Q3 | $542K | Hold |
7,041
| – | – | 0.01% | 1407 |
|
|
2021
Q2 | $661K | Buy |
7,041
+470
| +7% | +$47.4K | 0.01% | 1326 |
|
|
2021
Q1 | $716K | Sell |
6,571
-911
| -12% | -$96.3K | 0.01% | 1187 |
|
|
2020
Q4 | $772K | Hold |
7,482
| – | – | 0.01% | 1066 |
|
|
2020
Q3 | $603K | Sell |
7,482
-144
| -2% | -$12.4K | 0.01% | 1085 |
|
|
2020
Q2 | $645K | Hold |
7,626
| – | – | 0.01% | 1028 |
|
|
2020
Q1 | $579K | Sell |
7,626
-442
| -5% | -$40.4K | 0.01% | 968 |
|
|
2019
Q4 | $746K | Sell |
8,068
-165
| -2% | -$14.1K | 0.01% | 1085 |
|
|
2019
Q3 | $655K | Buy |
8,233
+630
| +8% | +$50.1K | 0.01% | 1121 |
|
|
2019
Q2 | $628K | Hold |
7,603
| – | – | 0.01% | 1162 |
|
|
2019
Q1 | $510K | Sell |
7,603
-799
| -10% | -$53.5K | 0.01% | 1284 |
|
|
2018
Q4 | $554K | Hold |
8,402
| – | – | 0.01% | 1132 |
|
|
2018
Q3 | $572K | Hold |
8,402
| – | – | 0.01% | 1267 |
|
|
2018
Q2 | $485K | Hold |
8,402
| – | – | 0.01% | 1334 |
|
|
2018
Q1 | $492K | Buy |
8,402
+136
| +2% | +$8.35K | 0.01% | 1284 |
|
|
2017
Q4 | $498K | Sell |
8,266
-9,684
| -54% | -$588K | 0.01% | 1293 |
|
|
2017
Q3 | $1.08M | Hold |
17,950
| – | – | 0.01% | 1206 |
|
|
2017
Q2 | $1.07M | Hold |
17,950
| – | – | 0.01% | 1207 |
|
|
2017
Q1 | $1.04M | Hold |
17,950
| – | – | 0.01% | 1216 |
|
|
2016
Q4 | $1.02M | Sell |
17,950
-602
| -3% | -$30.8K | 0.01% | 1286 |
|
|
2016
Q3 | $861K | Hold |
18,552
| – | – | 0.01% | 1365 |
|
|
2016
Q2 | $741K | Hold |
18,552
| – | – | 0.01% | 1440 |
|
|
2016
Q1 | $723K | Buy |
18,552
+377
| +2% | +$13.3K | 0.01% | 1347 |
|
|
2015
Q4 | $657K | Buy |
18,175
+1,278
| +8% | +$47.9K | 0.01% | 1448 |
|
|
2015
Q3 | $607K | Sell |
16,897
-3,280
| -16% | -$121K | ﹤0.01% | 1504 |
|
|
2015
Q2 | $755K | Sell |
20,177
-970
| -5% | -$36.6K | 0.01% | 1480 |
|
|
2015
Q1 | $824K | Sell |
21,147
-117
| -0.6% | -$4.38K | 0.01% | 1309 |
|
|
2014
Q4 | $785K | Sell |
21,264
-520
| -2% | -$18.6K | 0.01% | 1481 |
|
|
2014
Q3 | $758K | Hold |
21,784
| – | – | 0.01% | 1452 |
|
|
2014
Q2 | $755K | Hold |
21,784
| – | – | 0.01% | 1540 |
|
|
2014
Q1 | $767K | Hold |
21,784
| – | – | 0.01% | 1524 |
|
|
2013
Q4 | $746K | Buy |
21,784
+153
| +0.7% | +$5.27K | 0.01% | 1537 |
|
|
2013
Q3 | $719K | Sell |
21,631
-260
| -1% | -$8.58K | 0.01% | 1508 |
|
|
2013
Q2 | $709K | Buy |
+21,891
| New | +$755K | 0.01% | 1465 |
|
Other funds holding ESE
CIP
CCA
GCM
RA
Metropolitan Life Insurance Company (MetLife)'s ESE Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of ESCO Technologies (ESE) in Q2 2024, closing a stake of 1,330 shares — an estimated $142K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ESE in Q2 2013 and held it in 44 quarters. The position peaked at $1.08M in Q3 2017. 258 funds tracked by Wall St. Rank hold ESE as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining ESCO Technologies position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,330 ESCO Technologies shares in Q2 2024, an estimated $142K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in ESCO Technologies in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s ESCO Technologies position peaked at $1.08M in Q3 2017.
- 258 funds tracked by Wall St. Rank held ESCO Technologies as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.